DUPHAT Speakers

Prof. Abdullah Molokhia

Professor, Pharmaceutics, | Egypt

Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.

Dr. Abdullah Mohammed Al-Zahrani

Director of Pharmacy Services Department at Security Forces Hospital(SFHP) | Saudi Arabia

Dr.Alzahrani is a Consultant Clinical Pharmacist in Nephrology Pharmacotherapy, Currently is Director of Pharmacy Services Department at Security Forces Hospital(SFHP) – Riyadh, Saudi Arabia Dr.Alzahrani is scientific council member and member of central accreditation committee Saudi commission for health speciality(SCFHS) Dr. Alzahrani obtained his Doctorate of Pharmacy (Pharm.D.) degree from Campbell University, North Carolina, U.S.A in 2001, then he joins the ASHP General Pharmacy Practice Residency at Florida Hospital, Orlando, Florida U.S.A in 2002 In 2007, Dr. Al Zahrani started his own ambulatory clinic for management of post-renal transplant patient and hepatitis C patients. He is a member of many committees in hospital and nationally In 2011 Dr. Al-Zahrani joined the Saudi Pharmaceutical Society Board as the Management Board Secretary and the Chairman of Membership and Branches Committee. In 2014 Dr. Al-Zahrani elected to join the Saudi Pharmaceutical Society for another cycle. In 2017 Dr. Alzahrani elected as member of Saudi Pharmaceutical Society Board as the 3rd cycle Dr. Al-Zahrani presented a number of presentations over the years locally and internationally.

Dr. Abdullatif Alokifi

Asst. of Director General for GD of Hospital Affairs, General Supervisor of Wazen Program, Chairman of Hospital Commissioning Unit, Board Mbr Saudi Pharmaceutical Society – SPS, | Saudi Arabia

Dr. Abdullatif Alokifi is the Assistant of Director General for GD of Hospital Affairs, General Supervisor of Wazen Program and the Chairman of Hospital Commissioning Unit in Ministry of Health Headquarter. He used to be the Director of Strategic Planning and Operation in General Directorate of Quality and Patient Safety at Saudi Ministry of Health. He is the Board Member in Saudi Pharmaceutical Society. He was the CEO of Aljazeera Hospital in Riyadh KSA. He used to be the Quality Director of Alhammadi Hospital. He was the Assistant Head, Ambulatory Healthcare Center Department at CBAHI. He was the Associate Executive Director for Ancillary Services at King Abdullah Bin Abdulaziz University Hospital (KAAUH) and the Pharmacy Director belong to Princess Nora University (PNU). He was also the Director of Pharmacy and A/Head of Continuous Professional Development at Riyadh Care Hospital (RCH), Riyadh. He is working as Pharmacy Surveyor at Saudi Center for Accreditation of Healthcare Institutions (CBAHI) since 2010. He has activities as a Clinical Associated Professor for training of PharmD students in cooperation with Pharmacy College, King Saud University and as a Clinical Associated Instructor at Riyadh College for Dentistry and Pharmacy for Bachelor and Master Candidates. He has a lot of participations in pharmacy management, medication safety, quality and career development. Dr. Alokifi is distinguished speaker nationally and international. He got many award as best pharmacist and best preceptor from KSU and DUPHAT pharmacy international conference in Dubai. Dr. Alokifi got his bachelor’s degree in pharmacy 2000 from KSU, Pharmacy College and his Master’s Degree 2007 in Management and Hospital Administration. He conducted many projects and improvement initiatives in shape the good pharmacy practice using the current updated quality tools.

Prof. Abir Jaafar Hussain

Department of Electrical Engineering , College of Engineering University of Sharjah | United Arab Emirates

Abir Hussain is a professor of Machine learning and a member of the Electrical Engineering Department at University of Sharjah. She completed her PhD study at The University of Manchester (UMIST), UK in 2000 with a thesis title Polynomial Neural Networks for Image and Signal Processing. She has published numerous referred research papers in conferences and Journal in the research areas of Neural Networks, Signal Prediction, Telecommunication Fraud Detection and Image Compression. She is a PhD supervisor and an external examiner for research degrees including PhD and MPhil. She is one of the initiators and chairs of the Development in e-Systems Engineering (DeSE) series, most notably illustrated by the IEEE technically sponsorship.

Dr. Adnan Hajjiah

Clinical pharmacist, New Ahmadi Hospital, | Kuwait

Academic qualifications 2021 International Diploma for Healthcare Management 2012 MSc Clinical Pharmacy, University of Strathclyde 2006 Liverpool John Moores University, United Kingdom • Degree of Master of Pharmacy, with Honours, Class II, Division II Work Experience Oct 2021 – current date Clinical pharmacist in New Ahmadi Hospital Oct 2018 – Current date Pharmacist in New Ahmadi Hospital May 2017 – Sept 2018 Clinical preceptor for PharmD students (Kuwait Uni.) May 2016 – Oct 2017 Head of Self-assessment team in the pharmacy department (quality and accreditation team) Mar 2013 – Sept 2018 Clinical pharmacist in the intensive care unit (MKH) Sept 2013 – May 2015 teaching assistant at the Faculty of Pharmacy for third and final years pharmacy students involving dispensing techniques and clinical skills practices, respectively Aug 2007 – Sept 2018 Pharmacist in Mubarak Al-Kabeer Hospital (MKH) Aug 2006 – Aug 2007 Internship rotation, Ministry of Health, Kuwait

Dr. Ahmad Taqi

Assistant professor, Pharmacy Practice, Kuwait University | Kuwait

EDUCATION 2016-2018 Doctor Of Pharmacy Degree, MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCE (MCPHS) 2013-2014 MSc In Clinical Pharmacy, UNIVERSITY OF STRATHCLYDE, UK 2005-2009 Master Of Pharmacy (MPharm), LIVERPOOL JOHN MOORE’S UNIVERSITY, UK CERTIFICATION • Board Certified Infectious Diseases Pharmacist (BCIP) (2021-2027) • Board Certified Pharmacotherapy Specialist (BCPS) (2020-2026) • New England Postgraduate Pharmacy Teaching and Learning Certificate (2020) • Pharmacy-Based Immunization Delivery Certificate, American Pharmacists Association (APhA) • AHA Basic Life Support of Healthcare Providers • AHA Advanced Cardiac Life Support (ACLS)

Dr. AHMED IBRAHIM ALSAQER

ConsultManager, Pharmacy Services, Alhassa Consultant, Clinical Pharmacist | Internal Medicine Johns Hopkins Aramco Healthcare Pharmacy Services Department, | Saudi Arabia

Ahmed Alsaqer is a manger of Pharmacy services at Johns Hopkins Aramco Healthcare (JHAH), Alahssa. Dr Alsaqer also serves as Clinical Pharmacy consultant in Internal Medicine pharmacotherapy. He earned his bachelor of Pharmacy from Griffith University in Gold Coast, Australia, and master of Clinical Pharmacy from Curtin University in Perth, Australia. Dr Alsaqer completed PGY-1 pharmacy practice residency program at King Fahad Medical City, Riyadh, and PGY-2 Internal Medicine residency program at King Saud University Medical City, Riyadh. Dr Alsaqer recently completed his Master of Business Administration (MBA) from King Faisal University, Alahssa. In addition to his administrative role, Dr Al Saqer is dedicated to patient care provision, clinical rounds, and in-charge for Internal Medicine training in JHAH.

Dr. Ahmed Abdul Wahab Al-Amer

Pharmacist; Team Leader | Saudi Arabia

Dr. Ahmed Alamer has earned his Bachelor Degree in pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia in June 1996. Right after his graduation, he joined, Tabuk Pharmaceutical Factory, Jan 1997 to Sep. 1997 as medical representative. He is currently a senior pharmacist at National Guard Health Affairs - Primary Health care Jan 1998 till now. Dr. Alamer has actively involved in the DUPHAT Organizing Committee as a team leader to coordinate the pharmacy professionals’ participation in DUPHAT for more than 15 years. Dr. Alamer is active member of the Saudi Pharmaceutical Society and have been elected as a member of Al Hasa Pharmacy Club Adminsitaraive Board, and chosen as Chairman of Media & Publication Comiitteee of Al-Hasa Pharmacy Club. He is also member of patient medication safety committee in King AbdulAziz Hospital as representative of primary health care center, committee for preparing the center for accreditation as a family medicine training center, it's already has accredited since 2009. In addition, he is a member of Health promotion committee in primary health care center (activities organizer committee). On the international level, Dr. Alamer is member of scientific committee of Dubai International Pharmaceuticals and Technologies Conference (DUPHAT) 2010 – 2016. He attended and contributed in arranging many conferences, courses, symposium and workshops in and out of Saudi Arabia.

Prof. Albert Wertheimer

Nova Southeastern University, Florida, | USA

Dr. Albert Wertheimer has been active in sociobehavioral and administrative pharmacy research and education for more than 30 years. He earned a pharmacy degree at the University of Buffalo, an M.B.A. from the State University of New York at Buffalo and his Ph.D. at Purdue University. In addition, he completed a post-doctoral research fellowship in the department of social medicine at St. Thomas” Hospital Medical School of the University of London. He has directed nearly 100 Ph.D. students and more than that number of master’s students. He is the author or editor of 40 books, numerous book chapters and about 430 journal articles. He has lectured or consulted in about 75 countries, and he holds visiting professor appointments at universities in Mexico, Taiwan, Turkey, Slovenia and China. He performed pioneering work in the area of social and behavioral sciences in pharmacy and in more recent years has conducted research in pharmaco-economics, outcomes research, and health policy analysis. Prior to his appointment at NSU, he has been a professor at Temple University, dean of the Philadelphia College of Pharmacy, a researcher at Merck and Company, a vice president of First Health, Inc., a Pharmacy Benefit Manager and a professor and director of graduate studies at the University of Minnesota. Dr. Wertheimer has received many awards and recognitions including fellowships from the American Association of Pharmaceutical Scientists and the International Pharmacy Federation (FIP). He is Scheele Laureate and an honorary member of several professional societies. He has been a study section member/grant reviewer for the US NIH and for AHRQ. Current research interests include pharmaceutical counterfeiting, off label prescribing and cost:benefit studies.

Dr. Ali Hasan Alquraini

Faculty of Clinical Pharmacy, Al Baha University, | Saudi Arabia

Dr. Ali Alquraini is a Pharmacologist specializing in neuroinflammation. He received his BS degree in Pharmacy from the University of Jordan, and his MS and PhD in Pharmacology from Massachusetts College of Pharmacy and Health Sciences (MCPHS) University. After graduation, Dr. Alquraini completed his Postdoctoral Research Fellowship at Harvard Medical School and Massachusetts General Hospital in Boston (2019-2020). His research focuses on studying the role of scavenger receptors in neurodegeneration and inflammation and determining the roles of scavenger receptors such CD36 and LOX-1 in the pathogenesis of Alzheimer's disease. After postdoctoral work, he has joined the Faculty of Clinical Pharmacy at Al Baha University, where he is currently an Assistant Professor of Pharmacology in the Department of Pharmaceutical Chemistry. Dr. Alquraini has authored or co-authored several publications in peer-reviewed journals

Ms. Amal Al Shaaili

Clinical Pharmacist | Oman

Amal Ahmed Salim AL-Shaaili is a clinical pharmacist in Suhar Hospital a secondary care hospital in the Sultanate of Oman. She is responsible for developing clinical and educational initiatives designed to optimize drug therapy in the patient with kidney diseases .Although she has experience in both hospital in patient pharmacy and outpatient pharmacy practices. She is active in lecturing, research and clinical pharmacist with nephrologist. In additional to that she has been involved in drug therapeutic committee as a member. Adding to her role she is acting as Medication Safety Officer. This position involves measuring and improving medication safety in collaboration with multidisciplinary teams and individual clinicians. She evaluates medication events, quality metrics, and medication safety technology usage reports guides areas of focus. In addition, she precepts pharmacy students and develops nursing and pharmacy education as well as creates, edits, and provides lectures and patient education. Amal received her B- Pharm from Dubai Pharmacy collage in the Dubai-United Arab Emirates with very good grad, followed by MSc in Clinical Pharmacy and Service development from the Robert Gordon University-Aberdeen in the United Kingdom. During her study in Dubai she attended Duphat conference; 2005 as student participant, 2006 as poster represented &2007 as participant. Likewise during master study she trained in Scotland hospital at Aberdeen Royal Infirmary Hospital. Including to that she trained in many community pharmacies there which give her broad knowledge and experience in clinical pharmacy service and other pharmaceutical care services. Amal participated in many articles such as anti-coagulant therapy in hospitalized pregnant woman with COVD- 19 :A brief review , red man syndrome : beyond the story of Mississippi mud &antibiotic induced hypoglycemia. Including to that she is first author in study of evaluating the effective of anticholinergic drugs among elderly patient using ACB calculator.

Mr. Anas Nofal

Senior Director, Axios International Greater MENA | United Arab Emirates

Senior Director, Axios International Greater MENA

Dr. Anas Hamad

Director of Pharmacy Department National Center for Cancer Care & Research | Qatar

Director of Pharmacy Department National Center for Cancer Care & Research

Dr. Aymen Ali Alqurain

Acting Consultant Pharmacist, King Fahad General Hospital, Hofuf, | Saudi Arabia

Dr. Alqurain recently graduated from University of South Australia with a doctorate degree in pharmacology (therapeutics). He holds a bachelor degree in pharmacy from Curtin University and a master degree in palliative care from Flinders University. He is a registered pharmacist in Saudi Arabia and a researcher pharmacist in Australia. Dr. Alqurain worked in different clinical settings; ICU, Palliative care, Geriatric, Internal Medicine, and currently working as an acting consultant pharmacist in King Fahad Hospital in Hofuf. His research interests include quality use of medicines, medication safety, pharmacoepidemiology, pharmacokinetics and pharmacogenetics. He is also interested in optimising drug therapy for older people while addressing issues related to polypharmacy, inappropriate prescribing and deprescribing. Currently, he is a member of the following research centres, the Therapeutic Research Centre, Queensland, the Basil Hetzel Institute at the Queen Elizabeth Hospital in Adelaide, and the Health and Biomedical Innovation centre, Adelaide.

Mr. Bahgat Mohamed Fayed

Sharjah Institute for medical research, Sharjah University | United Arab Emirates

Bahgat Fayed is a Postdoctoral Research Associate at Research Institute of Medical & Health Sciences (RIMHS), Sharjah university. He is a member of the “Infectious disease and anti infective therapy research group” led by Dr. Sameh Soliman. He obtained his PhD in biology from University of York (UK). He has received the prestigious Fulbright award in 2018 to carry his research at UCLA, USA for 1 year. His research interest mainly focus on combating multidrug resistance microorganism by either discovery of novel antibiotics or deciphering the microbial resistance mechanisms.

Dr. Baltasar Pons

President of ASPROFA Community Pharmacist | Spain

Community pharmacist in Spain. President of ASPROFA (Pharmacy Professionals Association in Spain). Pharmacist of the year in Spain in 2017. Speaker in more than 100 conferences, courses and congress national and international. Council member of the Balearic Society of Cardiovascular Risk and Hypertension. Council member of Cooperativa d'Apotecaris (medication distribution warehouse). Member of FIP (International Pharmacy Federation), and poster presenter at the 3 FIP congress in Glasgow, Dusseldorf and Abu Dhabi

Ms. Ban Al-Joubori

Applied Biology, College of Sciences, University of Sharjah | United Arab Emirates

A lecturer at the Department of Applied Biology, University of Sharjah since 2010 with a PhD degree in Biosciences from the University of Birmingham.

Prof. Barry Bleidt

Professor, Socio behavioral and Administrative Sciences, College of Pharmacy | USA

Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.

Dr. Catarina Samorinha

Institute for Medical Sciences, University of Sharjah, | United Arab Emirates

Institute for Medical Sciences, University of Sharjah,

Ms. Dana Mazen Zaher

Sharjah Institute for medical research, University of Sharjah. | United Arab Emirates

Dana Mazen Zaher graduated from University of Sharjah in 2014 with a bachelor’s degree in Biotechnology with highest honors. She obtained her master’s and Ph.D. degrees with distinction in Molecular Medicine and Translational Research at the University of Sharjah, along with a dual Ph.D. degree from Lubeck University, Germany in 2021. Currently, Dana is a postdoctoral research associate at the Sharjah institute for Medical research. She is working in multiple projects in the fields of breast cancer, drug discovery and cancer metabolism. Dana published more than 20 research and review papers in high impact factor journals.

Prof. Dario Cattaneo

President of IATDMCT, Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milan, . | Italy

Dr. Dario Cattaneo has Pharmacy degree and post-degree specialization in Pharmacology both awarded by the University of Milan, Italy. PhD degree in Biomedical Sciences awarded by the Open University of London, UK. Later on, he obtained a Master of Transplant Medicine, University of Milan; Master of Clinical Research, University of Milan, Post-degree specialization in Nephrology, University of Ferrara; AssistantProfessor of pharmacology for the degree in Medicine, University of Milan. Dr. Dario Cattaneo was theHead of the Unit of Pharmacology and Pharmacogenetics, Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Since 2008 he is in charge of the Laboratory of Pharmacokinetics of the Unit of Clinical Pharmacology, Luigi Sacco University Hospital, Milano, Italy. From October 2019, President-elect, International Association of Therapeutic Drug Monitoring and Clinical Toxicology. His areas of interest are Pharmacokinetics, pharmacodynamics, pharmacogenetics and therapeutic drug monitoring of immunosuppressants, antiviral, antifungal agents, antibiotics, antipsychotics and hypolipidemic drugs. Development of chromatographic methods for the quantification of drugs in different biological matrices. Study of potential drug-drug interactions in real life settings. Dr. Cattaneo is the author of nearly 200 scientific articles published in peer-review journals (H-index 35), seven book chapters, and over 100 abstracts presented in different international congresses. Invited speaker in nearly 300 meetings organized by national and international societies.

Prof. Derek Stewart,

President European Society of Clinical Pharmacy , Professor Clinical Pharmacy & Practice, College of Pharmacy, Qatar University, Qatar" | Qatar

Professor Derek Stewart represents the European Society of Clinical Pharmacy. He is the current President of the Society and the Editor-in-Chief of the International Journal of Clinical Pharmacy. Originally from Scotland, he joined the College of Pharmacy at Qatar University in 2019 as Professor of Clinical Pharmacy and Practice. He is an internationally renowned educator and researcher, having published more than 200 peer reviewed papers, supervised over 25 PhD students to completion and attracted significant research income. He has been collaborating with several institutions in the Middle East for some time and has presented at DUPHAT on several occasions. His research focuses on: the development, implementation and evaluation of models of pharmacy practice, notably pharmacist prescribing; medicines use, effectiveness and safety; and educational innovation. The European Society of Clinical Pharmacy (ESCP) is an international association founded in 1979 by clinical practitioners, researchers and educators from several European countries. The overall mission of the society is to promote, support, implement and advance education, practice and research in clinical pharmacy in order to optimize outcomes for patients. Specifically, the society promotes the value and impact of clinical pharmacy services among health care professionals, scientific societies, health authorities and the public; and raises awareness of clinical pharmacy practice and its activities. Individual members include clinical pharmacists, hospital pharmacists, community pharmacists, researchers and educators from over 50 countries. Pharmacists, pharmacy technicians, pharmacy students and other healthcare professionals from any country working in the community, hospital, academic setting, industry or any other healthcare setting are eligible to become members of ESCP. There are two key annual events, a major symposium in October and a workshop earlier in the year. There are also a number of practice, research and education webinars and other key clinical pharmacy related products. https://escpweb.org/ "

Prof. Dr. Dieter Steinhilber

President of EUFEPS President, Goethe-University Frankfurt, | Germany

Prof. Dr. Dieter Steinhilber studied pharmacy at the University of Tübingen. After an assistantship there he spent a postdoc period with Nobel prize winner Prof. Bengt Samuelsson. In 1994 he received an associated professorship and since 2000 he is a full professor for Pharmaceutical Chemistry at the Johann Wolfgang Goethe University in Frankfurt am Main. From 1999 to 2008 and again since 2012 he is the director of this Institute. From 1999 to 2000, he was Dean of the Faculty Biochemistry, Pharmacy and Food Chemistry and from 2008 to 2010, he was the Dean of the Faculty of Biochemistry, Chemistry and Pharmacy. Prof Steinhilber was the chairman of a European Graduate Programs “Roles of Eicosanoids in Biology and Medicine” / Dr. Hans Kröner Graduiertenkolleg and is the chairman of the Else Kröner Fresenius-Graduiertenkolleg which are joint institutions of Goethe University and the Karolinska Institute. From 2001 to 2006 he was the chairman of the scientific board of the company Phenion. From 2012-2015 he was the President of the German Pharmaceutical Society (DPhG). From 2004-2012, he was a member of the "DFG-Fachkollegium Medicine" and represented the Pharmaceutical Sciences in the board of the Deutsche Forschungsgemeinschaft (DFG). Since 2005, he is chairman of the "Akademie für Pharmazeutische Weiterbildung der LAK Hessen". Since 2019, he is the President of EUFEPS. He has published around 300 papers in peer reviewed scientific journals. His h-factor is 41 and he has 7.280 cites. His research focusses on lipid signaling mechanisms in inflammation and cancer and new therapeutic strategies with a special focus on the arachidonic acid cascade

Dr. Dr. Feras Jirjees

Department of Pharmacy Practice & Pharmacotherapeutics College of Pharmacy University of Sharjah | United Arab Emirates

Dr Feras PhD in Pharmacy Practice and Clinical Pharmacy, Queen’s University Belfast, UK Assistant Professor, Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah

HE. Dr. Mohammed Suhail Al Mheiri

Board member of the Society, and head of the social service sector, Dar Al bar Society | United Arab Emirates

HE. Dr. Mohammed Suhail Al Mheiri, UAE Board member of the Society, and head of the social service sector, Dar Al bar Society

Prof. Dr. Sameh Soliman

Department of Medicinal Chemistry, College of Pharmacy | United Arab Emirates

Dr. Sameh Soliman has obtained his Bachelor and Master degrees in pharmaceutical sciences. He received his PhD from University of Guelph, Canada in chemical ecology of natural products and its role in host-microbe interactions. Then he did a Postdoctoral fellowship in mycotoxin manipulation and detoxification at Canadian Federal labs followed by another Postdoctoral fellow at UCLA in Chemical and biomolecular engineering of natural products. At UCLA Medical School he was trained on infectious diseases, pathogenesis mechanisms and possible ways in diagnosis and treatment. Currently, he is an associate professor at the Ccollege of Pharmacy, UOS, UAE. Dr. Soliman is leading projects in chemical ecology and biotechnology of medicinal plants growing in the UAE and discovery and development of effective antimicrobials from UAE natural resources and to optimize their structures and activities.

Prof. Emad Elazazy

Vice President and Secretary General of Egyptian Healthcare Society (EHS), | Egypt

He is a professor of governance and pharmaceutical practices at Cambridge regional U.K. and thesis advisor professor at diverse academic institutions. He had BSc. of pharm Sciences, Master of Business Administration; A.U.C., Doctor of pharmacy; Saskatchewan, Diploma in International-Economics; Cambridge, and PhD in Industrial Management, Aston University. Over the last fifteen years, he has been focusing on governance domains of practices for public, private and not-for-profit organisations, and extensively providing academic, educational and technical cutting-edge advisory consultations to a wide range of healthcare industries and academic circles on governance and health-economics. Dr Emad is the president of Value Institution for postgraduate education, a scientific board member at the National Training Institute (MOH) and a member of Governance and Social Accountability Task Force of MOH of Egypt. He also is a founding member, vice president and secretary general of Egyptian Healthcare Society, and a development committee member at the National Organization of Drug Control and Research (NODCAR). He worked for more than nine years as part-time consultant at WHOEMRO and Chairman of I.A.C. Middle East a Health Maintenance Organization. Dr Emad has been involved in and contributed to many international and regional researches on health systems, academic governance, health-economics, and governance structures and functions. As a governance adviser, he has conducted, directed and supported different governance processes at various local, regional and international assisted senior-level executives towards institutional governance enhancing operations and integration in academic governance, board governance, health and healthcare governance and health systems performance, reforms and restructuring contexts. Also, as international speaker and panellist Dr Emad delivered numerous speeches and published in different international journals on healthcare and governance related conferences and workshops. Also, he authored a number of books, articles, reports, toolkits, programs and curricula addressing post-graduate education and various aspects of academic, healthcare and governance foundations.

Dr. Eman Ali Algaai

Assistant Director of Training and Development Division, King Faisal Specialist Hospital and Research Center, Riyadh, | Saudi Arabia

Eman Al- Gaai, إيمان القاعي is a graduate of King Saud University, bachelor degree in pharmaceutical sciences, master degree in health and hospital administration, certified training manager, and a certified clinical research professional. She worked as a hospital pharmacist for 11 years followed by 15 years as Head of Clinical Research Services, Associate Scientist and Business Officer in the Department of Clinical Studies and Empirical Ethics, at King Faisal Specialist Hospital and Research Center, Riyadh. Currently she is the Assistant Director of Training and Development Division in the same institution. She has conducted several research projects of which some were funded by KACTS’ national science and technology plan and published more than 15 articles in peer-reviewed journals pertaining to clinical and empirical ethical research. She also serves as a manuscript reviewer in the British Medical Journal (BMJ) - Journal of Medical Ethics and BioMed Central ( BMC) Medical Ethics.

Dr. Eric Maroyka

Senior Director, Center on Pharmacy Practice Advancement, ASHP, | USA

Eric Maroyka, Pharm.D., BCPS, is the Senior Director, Center on Pharmacy Practice Advancement. He is responsible for the Practice Advancement Initiative focused on transforming the practice of pharmacy to enhance the role of the pharmacist in providing direct patient care services. Prior to his current position, he served as the Director of Pharmacy at Fauquier Health in Warrenton, Virginia. Dr. Maroyka also served over 22 years as a commissioned pharmacy officer in the United States Army working in a variety of clinical, pharmacy management/director, and senior leadership roles within the Military Health System. He earned a Bachelors Degree in Pharmacy and Pharm.D. from Rutgers University and completed a PGY1 Pharmacy Practice Residency at Walter Reed Army Medical Center. Dr. Maroyka is a Board Certified Pharmacotherapy Specialist and is a graduate of the Pharmacy Leadership Institute. Dr. Maroyka was a past appointed member of the ASHP Section of Pharmacy Practice Managers Section Advisory Group on Pharmacy Business Management and the Council on Pharmacy Management. He served as a delegate to the ASHP House of Delegates representing the Commonwealth of Virginia and as a Federal Delegate with the American Pharmacists Association. He currently serves as ASHP Secretary for the Council on Pharmacy Management and secretary for the Federal Pharmacy Consultants’ Advisory Group. Dr. Maroyka readily accepts and enjoys serving as a preceptor for student pharmacists and pharmacy residents. In addition to being a member of ASHP, Dr. Maroyka is also a member of the Virginia Society of Health-System Pharmacists, the American Pharmacists Association, and is a Knight in the Fourth Degree with the Knights of Columbus. Eric resides in Fairfax, Virginia with his wife of over 25 years and they have two daughters in college. In his free time, he enjoys traveling with his family, baseball, hiking, and volunteering his time to help those in need.

Ms. Eva Turgonyi

Medical Director GCC and Pakistan- AstraZeneca | United Arab Emirates

Medical Director GCC and Pakistan- AstraZeneca

Dr. Fadia Al Mahdi

Senior Manager Pharmaceutical Care & Management, Bupa Arabia | Saudi Arabia

Senior Manager Pharmaceutical Care & Management, Bupa Arabia

Dr. Fadilah Sfouq Aleanizy

Associate Professor of Pharmaceutical Microbiology and Biotechnology at the Department of Pharmaceutics, College of Pharmacy, King Saud University, | Saudi Arabia

Dr. Fadilah is an Associate Professor of Pharmaceutical Microbiology and Biotechnology at the Department of Pharmaceutics, College of Pharmacy, King Saud University. She has a Master degree in Clinical Microbiology from University of Nottingham, UK. Fadilah has earned her Ph.D. in Molecular Microbiology and Biotechnology from University of Nottingham, UK. Fadilah have both clinical and research microbiology experience. Microbiology is one of the most integrated and dynamic areas in medicinal field. Her pharmacy and microbiology training gives her an advantage in understanding and developing a good communication skills, which are important for team work and consultation with pharmacist, clinicians, nurses, students, patients. Dr. Fadilah also possess the leadership qualities. The clinical microbiology master program helped her master all areas of clinical and public microbiology and hone her research, teaching, and administrative abilities. After successfully completion, she committed herself to translational PhD research in order to achieve higher quality of exploration and learn modernized molecular techniques that may convert recent discoveries into cutting-edge tests and accelerate the integration of new molecular tests into clinical care in an academic setting. Dr. Fadilah received many awards from International and local conferences. Currently she is supervising Ph.D. students at the University of Brighton and King Saud University. In addition, she is supervising master students and graduation research students at King Saud University. Dr. Fadilah is a head of research groups at the department involved Pharmaceutical Microbiology, biotechnology and nanotechnology researches at the college of Pharmacy, KSU.

Dr. Faisal Alqarni

Cardiology Clinical Pharmacist, Security Forces Hospital Program, Riyadh, | Saudi Arabia

Faisal Alqarni is a cardiology clinical pharmacist at Security Forces Hospital Program - Riyadh, he earned his doctor of pharmacy (PharmD) degree from King Saud University in 2015. He has done his PGY-1 clinical pharmacy at Security Forces Hospital Program – Riyadh in 2017 - 2019, and his PGY-2 cardiology at Prince Sultan Cardiac Center in 2019 - 2020. Dr. Alqarni became an American Board-Certified Pharmacotherapy Specialist (BCPS) in 2018 and an American Board-Certified Cardiology Pharmacist (BCCP) in 2020.

Dr. Faisal ALsakr

Cardiac Clinical Pharmacist, Prince Sultan Cardiac Center, | Saudi Arabia

Faisal AL-Sakr is a cardiac clinical pharmacist at Prince Sultan Cardiac Center. He received his Doctor of Pharmacy degree from King Saud University – Riyadh in Jun 2015 and completed his PGY-1 Pharmacy Practice Residency in 2019 followed by PGY-2 cardiology Clinical Pharmacy at Prince Sultan Cardiac Center. Dr. ALsakr earned his Saudi board in cardiology clinical pharmacy in December 2020

Prof. Fakhr Zohair Al Ayoubi

President, Cardio Clinical Pharm Grp, Saudi Heart Assoc@SCCP2020, Intensivist Cardio.Clin.Pharmacist/Heart Failure Sp,College Medicine, Adjunct A.Prof.College Pharmacy,KingSaudUni | Saudi Arabia

Currently, she is the president of Saudi pharmacy specialist group at the Saudi Heart Association, Fakhr AlAyoubi, is the pioneer in utilizing metabolic syndrome pharmacotherapy in clinical practice focusing on Rare Disorders in Kingdom Of Saudi Arabia. Dr. Fakhr’s research team has published more than 30 scientific articles including the world’s largest pharmacy & metabolic syndrome studies on Saudi population & Gulf countries. as well as the the bleeding risk score multivariable module for Non-Valvular Atrial Fibrillation using DOAC in the Arab population. Her efforts have not only demonstrated on conducting clinical trials and multidisciplinary programs as a team work, but also in establishing as well as implementing different national guidelines, with the possibility of significant collaboration with MENA and Global Countries. Her team was able to do the world’s largest international health care practitioners & health technology gathering in the pandemic era under the name of SCOPE. As well as providing Educational webinars for Rare disease scientific awareness through conducting the Health Policy Assessment Unit. Now she is the chairman for our SHA site for Amyloidosis and the leader for the scientific committee for such project.

Dr. Fatema Alrashed

Assistant professor Kuwait University Department of Pharmacy Practice Kuwait | Kuwait

Professional Experience 2021 – Present Assistant professor Kuwait University Department of Pharmacy Practice Kuwait 2020 – 2021 Pharmacy Resident MelroseWakefield hospital Pharmacy Boston, MA 2019 – 2020 Clinical Research Fellowship MCPHS University/ Tufts Medical School Department of Pharmacy Practice Boston, MA 2018 – 2021 Adjunct Teaching Instructor Massachusetts College of Pharmacy and Health Sciences University Boston, MA 2018 – 2019 Pharmacy Fellowship Brigham and Women’s Hospital Department of Quality and Safety Boston, MA 2017 – 2018 Clinical Pharmacy Rotations (1500 hours) Massachusetts College of Pharmacy and Health Sciences University Boston, MA 2014 – 2015 Teaching Assistant Kuwait University School of Pharmacy Kuwait 2012 – 2014 Hospital Outpatient Pharmacist Mubark Alkabir Hospital Kuwait 2010 – 2011 Pharmacy Intern Alsaqir Polyclinic Kuwait Professional Education F. Alrashed 2 2019 – Present Master of Public Health MCPHS University (online) Boston, MA 2015 – 2018 Doctor of Pharmacy (PharmD) MCPHS University Worcester, MA GPA 3.77 2009 – 2010 Master of Science (MS) in Pharmacotherapy University of Sunderland United Kingdom 2005 - 2009 Master of Pharmacy (MPharm) John Moores University, School of Pharmacy Liverpool, United Kingdom Excellent with First Honors

Prof. Fernando de Mora

Professor of Pharmacology, Universidad Autonoma de Barcelona, | Spain

Full Professor of Pharmacology / PhD in immunopharmacology / University of Chicago MBA / Chairman of Pharmacology Dept. – Medical School / Principal Investigator in allergy projects / Postdoc at Harvard Medical School / International KOL in biotech science, regulation and market for private/public organizations (e.g. MoH, United Nations, DIA) / Manager of academic spin-off biosimilars company

Dr. Fulwah Y. Alqahtani

Associate Professor, College of Pharmacy, Pharmaceutics and Microbiology Department, King Saud University, | Saudi Arabia

Dr. Fulwah is an Assistant Professor of Pharmaceutical Microbiology and Biotechnology at College of Pharmacy, King Saud University. Previously, she worked as hospital pharmacist at King Abdulaziz Medical City (Saudi Arabia, 2005). She received her master’s degree in clinical microbiology from University of Nottingham in 2008 and Ph.D. in Molecular Microbiology and Biotechnology from University of Nottingham, U.K in 2012. Her PhD thesis entitled “Investigation of Galectin-3 interaction with N. meningitidis and its dimerization with laminin receptor’’ aimed to understand CNS tropism of meningococci, identification of meningococcal ligands and its implication in bacterial meningitis and potential vaccine candidates. Dr. Fulwah assigned as Assistant Vice Dean of the College of Pharmacy for Academic Affairs at King Saud University from 2015-2016. Supervisor of Academic Affair Unit from 2013-2015. Currently, she is a member in the many academic and scientific committees at College of Pharmacy and King Saud University. Through working with academic and scientists at King Saud University as senior investigator researcher in pharmaceuticals and molecular microbiology and biotechnology research group at the Pharmaceutics Department-Microbiology division, Dr. Fulwah has engaged in research activities enhance integration of molecular microbiology, cellular biology and clinical skills gained in her MSc and PhD In her current research. Dr. Fulwah research interests involve the understanding of pathogen-host interaction, microbial pathogenesis, and contribution of infectious pathogen in immune disease. She is also interested in fabrication of Nano-therapeutics for gene therapy of cancer, and antimicrobial agents against multi drug resistance bacterial isolates. Dr. Fulwah received many awards from International and local conferences. Currently she is supervising three master students as primary supervisor and two as secondary supervisor. Dr. Fulwah also supervises many graduation research students at King Saud University.

Dr. Grayson K. Peek

Director, Adult Clinic Pharmacy Operations, Vanderbilt University Medical Center, Nashville, . | USA

Grayson K. Peek, PharmD, MS, BCPS, currently serves as the Director of Adult Clinic Pharmacy Operations at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee, U.S.A. In this role, Dr. Peek is responsible for considerable COVID-19 operational and clinical planning through oversight of pharmacy services provided to Vanderbilt’s onsite and offsite clinic enterprise. Prior to VUMC, Dr. Peek served as the Manager of Business Development and Integrity within the Department of Pharmacy at Duke University Hospital (DUH) where he also completed a 2-year Health-System Pharmacy Administration Residency. Dr. Peek earned a PharmD from the University of Tennessee College of Pharmacy and a Master of Science in Health-System Pharmacy Administration from the UNC Eshelman School of Pharmacy.

Prof. H (Bert).G.M. Leufkens

Emeritus Professor of Utrecht University, Scientific Lead Lygature, Regulatory science and pharmaceutical policy Connector, | Netherlands

Bert is professor of Pharmaceutical Policy and Regulatory Science at Utrecht University. He obtained his PharmD and PhD degree from the same university. During the mid-80s he worked at Leiden University and was a Fulbright Fellow at the University of Minnesota (US). In 1997 he was appointed as full professor at Utrecht University. From 2003-2005 he was the Scientific Director of the Utrecht Institute for Pharmaceutical Sciences (UIPS), and during 2006-2007 head of the Depart­ment of Pharmaceutical Sciences of the Faculty of Science in Utrecht. Bert is research and policy-wise active at several (inter)national platforms on drug safety, pharmaceutical policy and regulatory science (e.g. past-member EMA Pharmaco­vigilance Working Party 2005-2009, chair of Dutch Medicines Evaluation Board (MEB) 2007-2017, past-member of the EMA CHMP 2009-2015, past-Pre­si­dent of ISPE, since 2008 Scientific Director of the Utrecht Centre for Pharmaceutical Policy and Regulation. He is affiliate professor at the Faculdade de Farmácia da Universidade de Lisboa and the Copenhagen Centre for Regulatory Science (CORS). He is (co) author of >500 papers in peer reviewed journals, book chapters and research reports. His key interests relevant for the Centre are pharmaceutical policy analysis, regulatory science, international health, risk assessment, public health, orphan drugs and scenario planning.

Dr. Hadi Mohamad Abu Rasheed

Head of Professional Development and Scientific Research Department Qatar Cancer Society | Qatar

Mohamad Abu Rasheed, Head of Professional Development and Scientific Research Department Qatar Cancer Society

Dr. Hamzah Alzubaidi,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah & Sharjah Institute for Medical Research, University of Sharjah | United Arab Emirates

Dr. Hamzah Alzubaidi currently works as an associate professor at the College of Pharmacy, University of Sharjah. Dr Alzubaidi has extensive experience in health services and population health fields, particularly in diabetes and CVD. Dr. Alzubaidi is currently leading a multi-dispensary research group focusing on improving health care delivery and chronic disease management. Dr. Alzubaidi has extensive experience in qualitative research methods.

Dr. Hana Al Ghussaini

Clinical Pharmacist | Oman

Hana Salim Sulaiman Al Ghussaini is a clinical pharmacist in Al Nahdha Hospital, a tertiary hospital in the Sultanate of Oman. In addition to her role as a clinical pharmacist, Hana is a member of the blood transfusion committee, research committee and pharmacy activities committee. She was a member of the Drug and therapeutic committee and patient safety committee. Furthermore, she is participating in the IV therapy course for nurses in the hospital. Hana received her Master of Pharmacy from Robert Gordon University-Aberdeen in the United Kingdom with Merit, followed by MSc in Clinical Pharmacy and Service development with Distinction from the same university. During her study, she trained in different hospitals in Scotland like Aberdeen Royal Infirmary Hospital and Raigmore Hospital in Inverness. Besides, she trained in many community pharmacies there which give her broad knowledge and experience in clinical pharmacy service and other pharmaceutical care services like medicines use review service, medicine reconciliation, smoking cessation and many other services. That opportunities with her speciality in clinical pharmacy and service development make her a cornerstone in initiating any pharmaceutical service in the hospital. As a clinical pharmacist, Hana is very precise and cares a lot about time management and teamwork. As a multidisciplinary team member, she is a trusted resource for all doctors in the hospital as she checks all patient prescriptions clinically and suggesting the most suitable drug as per the indication of the patient’s disease. Furthermore, she answers any question from the doctors and nurses related to the doses, compounding or dilution formula. Furthermore, she counsels patients inside the ward after discharge on potential side effects and drug interaction. Hana participated in many researches. The three major researches she leads was ‘’ Analysing antibiotics prescriptions in outpatient clinics and emergency department in Al-Nahdha Hospital in Oman’’, The knowledge, attitude and practice of parents in respect of antibiotic use for common upper respiratory tract infections in paediatric patients at Al-Nahdha hospital in Oman’’ and ‘’ Are pharmacists ready to change? pharmacy students’ expectation of pharmacy career’’.

Dr. Hawra AlSayed

Pharmacist, Dubai Health Authority | United Arab Emirates

Pharmacist, Dubai Health Authority

Ms. Heba , Rashed

Founder & Executive Director at Mersal Foundation | Egypt

Ms. Heba Rashed, Egypt Founder & Executive Director at Mersal Foundation

Prof. Hissam Tawfik

Electrical Engineering Department, College of Engineering, University of Sharjah | United Arab Emirates

Hissam Tawfik is a Professor of Artificial Intelligence. He holds a PhD in Computer Engineering from the University of Manchester (UK) and has a research track record of more than 150 refereed publications in international journals and conference proceedings in Applied Artificial Intelligence, Biologically Inspired Systems, and Data Science. Hissam is an editor of the International Journal of Neural Computing and Applications and International Journal of Reliable Intelligent Environments, and a chair of the International Conference Series on Developments in eSystems Engineering (DESE).

Prof. Hoai-An Truong

Director of Public Health, School of Pharmacy & Health Professions, Maryland University, | USA

Education Master of Public Health (2007) – University of Maryland School of Medicine, Baltimore, MD APhA-ASHP Accredited Post-Graduate Residency Training in Pharmacy Practice with an Emphasis in Community (2006) – University of Maryland School of Pharmacy, Baltimore, MD and Happy Harry’s Pharmacy, Perryville, MD Doctor of Pharmacy (2005) – University of Maryland School of Pharmacy, Baltimore, MD Pre-Pharmacy with Concentration in Biochemistry (2001) – The Catholic University of America, Washington, DC Bio Dr. Truong has been public health pharmacist and educator over thirteen years. He provided patient-centered care in interprofessional clinics to optimize medication use and health outcomes, as well as developed and implemented population-based programs to improve community health. He has served as coordinator and preceptor for pharmacy, physical therapy, physician assistant, and public health students on five medical missions to Haiti and Vietnam. Currently professor and director of public health at University of Maryland Eastern Shore (UMES) School of Pharmacy and Health Professions, Dr. Truong was founding chair of the Eastern Shore Collaborative for Interprofessional Education (ESCIPE), an interprofessional, inter-institutional initiative with Salisbury University. Previously, he was founding chair of the department of pharmacy practice at West Coast University School of Pharmacy, founding assistant dean for professional affairs at UMES, and assistant then acting executive director of experiential learning program at University of Maryland Baltimore. Hoai-An was also clinical coordinator/pharmacist at Happy Harry’s a Walgreens Pharmacy Patient Care Center. As a practitioner-educator, he provided medication management to improve healthcare access for underserved populations in interprofessional clinics of the Primary Care Coalition. The team received a Life-saving Patient Safety Award and was featured in Pharmacy Today magazine in 2012. He is also a trainer for the American Pharmacists Association’s medication therapy management national certificate program and trained over 600 pharmacists. Dr. Truong published over twenty peer-reviewed articles and book chapters and presented at multiple national and international conferences. He is co-editor and co-author of a book, The Pharmacist in Public Health: Education, Application, and Opportunities, published by the American Pharmacists Association in 2010. He is past chair of the Public Health Special Interest Group (PHSIG) of the American Association of Colleges of Pharmacy (AACP). He is past president of the Maryland Public Health Association, past president of the Maryland Pharmacists Association, and past president of the Alumni Association of the University of Maryland School of Pharmacy. Hoai-An received the Excellence in Public Health Pharmacy Practice Award from the U.S. Public Health Service, Excellence in Innovation Award from the Maryland Pharmacists Association, and was inducted as a Fellow of the American Pharmacists Association and Fellow of the National Academies of Practice. Areas of Interest and Experiences Health Promotion and Disease Prevention Interprofessional Education and Practice Global Health and Medical Mission Leadership and Professional Development

Dr. Ibrahim Al-Khars

Business Development Manager and Senior Consultant for People & Business Development Center | Saudi Arabia

Dr. Ibrahim Al-Khars is working as Managing Director, Business Development Manager and Senior Consultant for People & Business Development Center, Dammam, Saudi Arabia. Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.

Ms. Iqra Jilani

Business Excellence and Engagement, Axios International | United Arab Emirates

Business Excellence and Engagement, Axios International

Dr. Isra Al Lawati

Head of the pharmaceutical care services | Oman

Isra Al Lawati earned her postgraduate degree in MSc Clinical Pharmacy Service Development at the Robert Gordon University in Aberdeen, United Kingdom in January 2017. She earned her undergraduate degree (Bachelor) in pharmacy at Oman Medical College, Muscat in February 2011. In 2011 she joined the department of pharmacy at Al Masarra Hospital and worked as an in-charge of in-patient pharmacy for 2 years. From 2017 up to July 2021, she was working as Clinical Pharmacist specialist in the psychiatric field, mainly responsible for reviewing patients admitted in the hospital by reviewing their medications and identifying related problems, attending major rounds, applying medicine reconciliation process, providing counseling sessions and applying poly-pharmacy service in the department. She has made numerous presentations to other healthcare professional at hospital level and national level focusing in Pharmaceutical care. Aside from Isra's clinical experience in the pharmaceutical care inside the pharmacy department, she was the leader of the patient safety friendly hospital program of the pharmacy theme in Al Masarra Hospital and member of Smart pharmacy program as smart pharmacist which had been applied in Oman since 2017. She was the leader of poly-pharmacy service of the hospital and had given poster presentation in the first international patient safety day in September 2019. Moreover, she was a member of the local guidelines committee, who were responsible for developing internal policies and guidelines for the hospital sector. And a member of the research committee in the Hospital who were responsible for conducting researches and studies related to the services provided in the hospital. Now she is working as section head of the pharmaceutical care services of the hospitals in the pharmaceutical care department in the Directorate General of Medical Supplies (DGMS).

Dr. Joaquima Serradell

Temple University Hospital, Philadelphia, PA, | USA

Temple University Hospital

Prof. John Papstergiou

Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada. | Canada

John Papastergiou graduated from the Leslie Dan Faculty of Pharmacy, University of Toronto in 2002. After graduation he was employed as a staff pharmacist at Sunnybrook Health Sciences Center. In 2005, John joined Shoppers Drug Mart and acquired his first store at Pape and Danforth. He now owns and operates four locations in downtown Toronto. In 2014, John received an appointment as an adjunct assistant professor at the School of Pharmacy, University of Waterloo. In 2016, he was cross appointed at the Leslie Dan Faculty of Pharmacy, University of Toronto. In addition to managing a large business, John employs his unique background in clinical research to explore an expanded role for the community pharmacist. John strongly believes that the accessibility of the community pharmacist places them in a unique position to actively screen and monitor patients for various chronic diseases. Most recently, he implemented one of the first frontline community pharmacist-directed pharmacogenomics clinics in Canada. His work in this area won first prize at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences in Buenos Aires, Argentina. John can be heard regularly on the Libby Fights Back Show on AM740 Zoomer Radio and on his top-rated podcast The Pharmacists Are In. In 2012, John was named the Shoppers Drug Mart Associate of the Year. In 2014, he received the OPA Mentorship Award and was named CPhA Canadian Pharmacist of the Year. In 2016, he was the recipient of the OPA Voice of the Profession Award and was awarded the Pharmacy Practice Commitment to Care Award for Overall Patient Care. In 2019, John was named by the International Forum on Advancement in Healthcare as one of the top 100 healthcare leaders globally. He was also presented with the OPA Award for Excellence in Research and Academia

Prof. Kenneth I. Kaitin

Center Director & Research Professor, Tufts University School of Medicine, | USA

Kenneth Kaitin is a Professor at Tufts University School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University, and he serves on the faculty of the European Center for Pharmaceutical Medicine at the University of Basel. An internationally recognized expert in drug development science and policy, Dr. Kaitin writes, speaks, and teaches on global trends in pharmaceutical development and regulation, and he has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, Dr. Kaitin is currently Editor-in-Chief of Expert Review of Clinical Pharmacology, and he is a consultant to the U.S. Department of Defense on bioterror countermeasures. In 2011, he received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators. Dr. Kaitin serves on several public and private company boards of directors. He received his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.

Dr. Khalid Al Kubaissi,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah. | United Arab Emirates

Dr Khalid received his PhD in 2019 from University of Gloucestershire, United Kingdom, his first master was in public Health in 2012 from Hamdan Bin Mohammed Smart University Dubai (HBMSU); his second master was in Clinical pharmacy in 2020 from Ajman University and his BS in pharmacy in 1995 from the faculty of Pharmacy, University of Baghdad, Iraq. Dr. Khalid has considerable hospital pharmacy experience and community pharmacy research. He is the invited speaker at multiple regional and international conferences, and the principal investigator of several research projects focusing on pharmacy practice and community pharmacy services in the UAE and the region.

Prof. Linda S. Tyler,

Pharm.D., FASHP, Professor (Clinical) of Pharmacotherapy, University of Utah College of Pharmacy, | USA

LINDA S. TYLER, Pharm.D., FASHP, is Professor (Clinical) of Pharmacotherapy, University of Utah College of Pharmacy. Previously, she was the Chief Pharmacy Officer for University of Utah Health; and Associate Dean for Pharmacy Practice, University of Utah College of Pharmacy. Tyler received her B.S. in Pharmacy and Pharm.D. degrees from the University of Utah. She completed a pharmacy practice residency at University of Nebraska Medical Center. She was a faculty member and critical care practitioner at the University of Wisconsin and a poison control center specialist at Nationwide Children's Hospital. She returned to the University of Utah as Director of Drug Information Services. She served in that role for many years before becoming the senior pharmacy leader for University of Utah Health. Tyler is a tireless advocate for progressive and innovative pharmacy services in health systems. She was the residency program director for the HSPAL program and prior to that for the Drug Information residency. Tyler has served ASHP in many capacities, most recently as President. She previously served as a Board Member, Chair of the Council on Pharmacy Management and as Director-at-Large of the Section of Clinical Specialists and Scientists Executive Committee. She has also served on the Councils on Organizational Affairs, Therapeutics, Education and Workforce Development, and Pharmacy Practice; the Committee on Nominations; Section of Ambulatory Care Practitioners; New Practitioner and Student Forums; and a delegate to the House of Delegates for many years. She is a Past President of USHP. Dr. Tyler was the 2015 recipient of the John Webb Award, given by ASHP in recognition of outstanding leadership.

Dr. Maha Saber-Ayad,

Clinical Sciences, Medicine, University of Sharjah | United Arab Emirates

Maha Saber-Ayad is a Professor of Pharmacology, UoS. She was graduated in the College of Medicine, Cairo University, with PhD in pharmacology 2006, fellowship of the Royal College of Physicians (Edinburgh) in 2013, MSc in Endocrinology and DM, Queen Mary University of London, 2017. Her research domains include applied genetics including pharmacogenomics, as well as cancer research. She is the PI of projects funded by the University of Sharjah, Al Jalila Foundation, MBRU-Al Mahmeed Research Award and Sheikh Hamdan Medical Research Grant.

Dr. Mahmoud Fahmi Elsebai

Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Egypt | Egypt

Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Egypt

Dr. Majid Ali

Adjunct Fellow , Faculty of Health & Medical Sciences, University of Adelaide, Lecturer in Clinical Pharmacy, University of Hertfordshire, | Egypt

Adjunct Fellow , Faculty of Health & Medical Sciences, University of Adelaide, Lecturer in Clinical Pharmacy, University of Hertfordshire,

Dr. Manal AL Sha'rawy

Department of Pharmacy Practice & Pharmacotherapeutics College of Pharmacy University of Sharjah | United Arab Emirates

Master in Analytical Toxicology- Forensic Medicine University of Jordan Amman- Lecturer in Pharmacology Lecturer, Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah

Dr. Mark Rawas Qalaji

Department of Pharmaceutics and Pharmaceutical Technology College of Pharmacy, University of Sharjah | United Arab Emirates

Dr. Qalaji (B. Pharm, PhD), Associate Professor and Chairman of the Department of Pharmaceutics and Pharmaceutical Technology. Dr. Qalaji is the Founding Leader for the Drug Delivery research group at the University of Sharjah and the Founding Director for the Drug Discovery and Development Center at Nova Southeastern University, Florida, USA. Dr. Qalaji is the inventor for 18 issued patents in various countries (US, UK, German, France, Italy, Spain, Portugal, Denmark, and Turkey) and 48 other patent applications. Dr. Qalaji research focus on the formulation, development of novel dosage forms and drug delivery through non-invasive routes.

Mr. Marwan Abdulaziz Janahi,

Rare Diseases Society & Managing Director, Dubai Science Park | United Arab Emirates

Chairman, Rare Diseases Society & Managing Director, Dubai Science Park

Dr. Maryam Al Khateri,

Gastroenterologist and Head of Department, IBHOHospital & Former President of the Emirates Gastroenterology and Hepatology Society | United Arab Emirates

Dr. Maryam Al Khateri, UAE Gastroenterologist and Head of Department, IBHOHospital & Former President of the Emirates Gastroenterology and Hepatology Society

Dr. Michael DeCoske,

Assistant Vice President of Ambulatory Pharmacy Services , Baptist Health, Florida, | USA

"Michael DeCoske currently serves as Assistant Vice President of Ambulatory Pharmacy Services at Baptist Health South Florida in Miami, Florida. Prior to this role, he served as Associate Chief Pharmacy Officer for Ambulatory Services at Duke University Hospital in Durham, North Carolina. Dr. DeCoske completed a PGY1 and Health System Pharmacy Administration (PGY2) Residency at the Medical University of South Carolina in Charleston, South Carolina. He completed his Doctor of Pharmacy degree at Duquesne University in Pittsburgh, Pennsylvania. Dr. DeCoske is committed to professional pharmacy involvement. He is a fellow of the American Society of Health System Pharmacists. He served as a voting member at the 2010 ASHP Pharmacy Practice Model Summit, the 2014 ASHP Ambulatory Care Pharmacy Summit and the 2021 ASHP Specialty Pharmacy – Future Directions Summit. He has held numerous leadership positions within ASHP, most recently serving as Chair of the Section of Specialty Pharmacy Practitioners Business Development Section Advisory Group. He is a co-author of the ASHP Pharmacy Leadership Field Guide. DeCoske holds distinction as a Board Certified Pharmacotherapy Specialist."

Dr. Mohamed Adel Moufti,

Department of Preventive and Restorative Dentistry College of Dental Medicine, University of Sharjah | United Arab Emirates

Dr Adel Moufti is an Assistant Professor in Prosthodontics at the University of Sharjah. He received his PhD degree from Newcastle University and lectured in the UK for 10 years. He was the recipient of the prestigious “Asian Professionals Awards in the UK” in recognition for his research and contribution to Dentistry in the UK. Having pursued further education from Harvard Medical School, he is leading several research projects on Artificial Intelligence and the Digital Transformation in Healthcare.

Dr. Mohamed Ahmed Awad Saleh,

Clinical Sciences Department, College of Medicine University of Sharjah | United Arab Emirates

Dr. Saleh received his Ph.D. degree from Augusta University, Georgia, USA in the field of Biomedical Sciences (Pharmacology). In 2012, he received a post-doctoral fellowship in Vanderbilt University, Tennessee, USA. During 2012-2016, his postdoctoral work focused on investigating a totally new link between inflammation and cardiovascular diseases. Dr. Saleh received several recognitions from the American Heart Association (AHA) and the American Physiological Society (APS) during his Ph.D. and postdoctoral fellowship. His scientific production is reported in more than 40 publications in leading highly impacted international biomedical journals. In 2022, his “h-Index” reached 23 according to “SCOPUS” data base evaluation system.

Dr. Mohamed Haider

Department of Pharmaceutics and Pharmaceutical Technology College of Pharmacy, University of Sharjah | United Arab Emirates

Mohamed Haider (PhD, MBA) is an associate professor in the Department of Pharmaceutics and Pharmaceutical Technology and the founder of the Drug Delivery research group at the College of Pharmacy, University of Sharjah. His research interests focus on the biomedical applications of nanotechnology, sustained release systems and hydrogels for drug delivery and cell-based therapy.

Dr. Mohammad AlSharhan,

Chairman, Patients Helping Fund Society | Kuwait

Dr. Mohammad AlSharhan, Kuwait Chairman, Patients Helping Fund Society

Dr. Mohammad Alshabeeb

Clin. Pharmacist, Pharmacogenomics Consultant, Assoc. Research Scientist, Population Health Research Section, KAIMRC), Min. National Guard - Health Affairs, | Saudi Arabia

Dr. Mohammad Alshabeeb is a Pharmacogenomics Consultant currently working as an Associate Research Scientist in the Population Health Research Section at King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard – Health Affairs in Riyadh, Saudi Arabia. He graduated from King Saud University, College of pharmacy with a Bachelor’s degree in Pharmaceutical Sciences in 1994. In 1999, he earned a Master’s Degree in Clinical Pharmacy from King Saud University, College of Pharmacy. He worked for 9 years as a clinical pharmacist providing pharmacotherapy consultations to different medical teams. In 2009, he completed another Master’s Degree in Molecular and Medical Biosciences, and then obtained the PhD Degree in Pharmacogenetics in 2014 from Newcastle University, UK. Finally, a post-doctoral fellowship training program was completed in 2017 at Utrecht University in collaboration with the Cardiovascular Genetic Research Department at University Medical Center in the Netherlands. Dr. Alshabeeb has several peer reviewed publications and abstracts in various international journals.

Dr. Mohammad Alqudah

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates

Dr. Mohammad Alqudah is Associate Professor of Clinical Pharmacy. He received his PharmD degree from Jordan University of Science and Technology (2008) and his PhD from University of Iowa (2013). His research interests span both clinical and experimental therapeutics with special emphasis on cancer and neuropsychiatric diseases

Dr. Mohammed Omair

Consultant Rheumatologist and Assistant Professor in King Saud University (KSU) | United Arab Emirates

Consultant Rheumatologist and Assistant Professor in King Saud University (KSU)

Dr. Mohammed ALShennawi

Office of Assistant Deputy Minister for Supportive Medical Services, Ministry of Health | Saudi Arabia

Dr. Mohammed ALShennawi, KSAOffice of Assistant Deputy Minister for Supportive Medical Services, Ministry of Health

Dr. Mohammed Al Mohaini

Asst Prof. Pharmacology, Research Coordinator, Basic Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Alahsa, | Saudi Arabia

Academica Electronic Portfolio (ePortfolio) is considered a student-oriented learning method. ePortfolio is created by a student of his/her course-related work such as artwork, essays, photographs, posters, and videos. In addition, ePortfolio includes other activities related to student’s experience like extracurricular activities, volunteer and employment experiences. Therefore, ePortfolio is a method of assessment that provides faculty ways for continuous collecting and assessing a student’s work, and gives the student and faculty an opportunity for evaluating the progress during a course. The importance of ePortfolio for pharmacy students as a method of learning and assessment is that it provides the student a way of reflection on his/her learning experience. In addition, faculty feedback is an essential part for an effective and productive ePortfolio in which there is a strong relationship between student’s reflection and faculty feedback. In conclusion, implementing ePortfolio will improve the education process in a pharmacy-based setting.

Mr. Mohammed Aseeri

Assistant Pharmacy Director, Clinical Services, King Abdul Aziz Medical, Jeddah, | Saudi Arabia

Dr. Aseeri is currently an assistant pharmacy director for the clinical services at King Abdul Aziz Medical in Jeddah which is a 700 bed academic tertiary care facility belongs to the ministry of National Guard Health Affairs in Saudi Arabia. Dr. Aseeri graduated from the college of pharmacy at King Saud University in Riyadh with a bachelor degree in pharmaceutical sciences in 2000. After his graduation, he worked as a staff pharmacist at King Khalid National Guard Hospital in Jeddah, Saudi Arabia. In 2003, Dr. Aseeri was awarded a scholarship from the National Guard Health Affairs to complete a post graduate training in clinical pharmacy field in North America. He obtained in 2006 his Doctor of Pharmacy degree (Pharm.D.) from North Dakota States University and completed an ASHP accredited PGY1 pharmacy residency training in 2007 at Wesley Medical Center in Wichita, Kansas. In 2013, he completed a fellowship training program in safe medication management at the Institute for Safe Medication Practices (ISMP) in Pennsylvania, USA. In addition to his clinical practice and management positions, he is an associate professor for clinical pharmacy at King Saud bin Abdul Aziz University for health Sciences.

Dr. Mohannad Nassar

Department of Preventive and Restorative Dentistry, College of Dental Medicine, University of Sharjah. | United Arab Emirates

Dr. Mohannad Nassar is an assistant professor of endodontics and currently serves as the vice president of the UAE section of the International Association for Dental Research (IADR).

Dr. Mohd Shara,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah. | United Arab Emirates

Mohd A, Shara, PharmD (1985), Ph.D., (1990), University of Nebraska Medica Center, Omaha, NE, USA. and Fellow of the American College of Nutrition (FACN) has been involved clinical pharmacy practice and teaching for the last 35 years (25 years in the US and 10 years in Jordan) at Creighton University School of Pharmacy, Omaha, NE and Jordan University of Science and Technology.

Dr. Mona Mataqi

Clinical Pharmacist, Adan Hospital, | Kuwait

Personal Statement I’m the clinical pharmacist of the ICU in Adan Hospital and part of their ECMO multidisciplinary team and COVID team. I am also working in Jaber Al-Ahmed Hospital Intensive Care Unit since 19th of March 2020. Education 2018-2019 University of Hertfordshire Advance Clinical Pharmacy Practice MSc Year: 1 2012-2016 University of Bradford Mpharm Course Year: 4 2011-2012 INTO University of East Anglia Foundation Science - Pharmacy, Biomedicine, Health Modules included: Mathematics, Physics, Chemistry, Biology, Human Physiology and Further Chemistry 2010-2011 Bath Academy Intensive English Course ILETS Score: 7.0 2006-2010 Jabreya High School for Girls High School Certificate 92% overall Work Experience May 2021- Preceptor of PharmD Students at Kuwait University I had the opportunity of supervising and training a PharmD student last year in Al-Adan ICU for 5 weeks. I assisted the student in the application of university taught knowledge and information into direct patient care and facilitates the application of theory to practice. This experience helped shape and enhance my teaching skills.

Dr. Muhannad Alharbi

Health Economics Consultant, HEPA Solutions Company, | Saudi Arabia

Dr. Muhannad Alharbi is health economics Advisor and founder of HEPA platform for digital health economics tools with Artificial Intelligence (AI). He holds a PharmD degree from King Abdul-Aziz University. He received his master’s degree in Drug Development and Economic Product management from University of California, San Diego, US. His background professional experiences shaped from working at pharmaceutical industries and consulting firm. - Health Economics Consultant at HEPA Solutions Company - Lecturer in Saudi Health Saudi Commission for Health Specialists - Pharmacoeconomics and pricing Advisor at SFDA - A Peer Reviewer and Speaker in ISPOR European and Saudi Arabia Chapter - Cooperative Researcher at King Saudi University - Independent Consultant in Economic Data Analytics for governmental and private sector

Dr. Nadia Rashed Al Mazrouei,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah. | United Arab Emirates

Dr. Nadia has a Ph.D, MSc in Clinical Pharmacy, Queen`s University of Belfast, Uk And B.Sc., Pharmaceutical Sciences with honors, Cairo University,Egypt - Member of Expert advisory Panel for pharmacopiae and pharmaceutical preparation in WHO - Member of One FIP Data and Intelligence commission in International Pharmacy Federation, FIP - Member of identifying and addressing the multi-national education and training needs of the pharmaceutical workforce (METNA)/ FIP - President of EMR Eastern Mediterranean Region Forum /FIP - Former Deputy Director of Military Medical Services, UAE - Also she was Logistic Director and Chief Pharmacist in Zayed Military Hospital, Directorate of Military Medical Services, UAE

Dr. Nadiya Al Balushi

Pharmacist & Medical Store In-charge of BSPC | Oman

Is an Omani specialized pharmacist working in the Ministry of Health in Oman (Muscat) for 19 years. She received her Master of Science in Clinical pharmacy from the University of Strathclyde in 2013. She started a service in Bowsher Specialized clinic in 2014, aiming warfarin patients to increase their compliance and knowledge by which with team in PT clinic achieved best care. From 2017 to 2021, being the pharmacist and medical stores In-Charge who had a hand in care and service improvement at Bowsher Poly Clinic. On October 2020 joined team of quality assurance & patient safety directorate in ministry of health to input the medication safety and patient safety department nationally. Recently involved in medication electronic incident reporting & learning system analysis aiming improvement of reporting.

Dr. Nelson Alexandre da Cruz Soares

University of Sharjah, College of Pharmacy – Department of Medicinal Chemistry | United Arab Emirates

University of Sharjah, College of Pharmacy – Department of Medicinal Chemistry

Ms. Noha Mousaad Elemam ,

Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, UAE | United Arab Emirates

Noha Mousaad Elemam graduated from the German University of Cairo with a bachelor’s degree in Pharmacy and Biotechnology and a master’s degree in Molecular Pharmacology. Noha was awarded her Ph.D. degree with Distinction in Molecular Medicine and Translational Research at the University of Sharjah, along with a dual Ph.D. degree from University of Lübeck, Germany. Currently, Noha is a postdoctoral research associate at the Sharjah Institute for Medical Research at the University of Sharjah, where she is working on multiple projects in the fields of immunology, breast cancer as well as COVID-19 infection. Noha published more than 40 research and review papers in high impact factor journals and she is a co-inventor in a patent filed in the US patent office as well as being a co-investigator in multiple grants at the University of Sharjah.

Dr. Nooshin Bazargani

Cardiology Dept, Dubai Hospital | United Arab Emirates

Cardiology Dept, Dubai Hospital

Dr. Nora Al Thumiri,

Researcher, Co-Founder, and CEO of Sharik | Saudi Arabia

Dr. Nora Al Thumiri, KSA Researcher, Co-Founder, and CEO of Sharik

Ms. Nora Al Khudair

Head of Experiential Education Unit at King Saud University, King Saud University - Saudi Oncology Pharmacy Assembly (SOPA) | Saudi Arabia

Ms. Nora Al Khudair, KSA Head of Experiential Education Unit at King Saud University, King Saud University - Saudi Oncology Pharmacy Assembly (SOPA)

Dr. Ohoud Aljuhani

Assistant Professor of Pharmacy Practice, at Faculty of Pharmacy in King Abdulaziz University, Consultant Critical Care Pharmacist, King Abdulaziz University Hospital, | Saudi Arabia

Dr. Ohoud Aljuhani, PharmD, BCCCP, Assistant Professor of Pharmacy Practice, at Faculty of Pharmacy in King Abdulaziz University. Consultant Critical Care Pharmacist at King Abdulaziz University Hospital. She focuses on critical care medicine, including post ICU survivors’ outcomes, ICU protocols developments and implementation, pain, sedation, and ICU delirium management. Dr. Aljuhani completed an ASHP accredited general pharmacy residency followed by an ASHP accredited specialized pharmacy residency in Critical Care Pharmacy from University of Arizona Medical center (Level one trauma center), Tucson, AZ, USA. She received two years of Post doctorate fellowship specialized in Critical Care clinical research from the college of pharmacy at University of Arizona, Tucson, AZ, USA. Dr. Aljuhani was among the first group of pharmacists in the world who passed the board certification in critical care pharmacy exam in its first version in 2014. She has published multiple critical care related papers and book chapters. Her areas of interest include: Critical care research related to trauma and life support, acute pain, sedations, ICU delirium, analgesia, fluids management, patients related health outcomes, and post ICU survivors’ quality of life. Teaching and training for critical care and emergency medicine topics, life threatening infections, pharmacy practice professionalism and communications. Academic advising and career counseling. Undergraduate and postgraduate mentoring.

Dr. Osama Ibrahim,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah. | United Arab Emirates

Dr. Osama Ibrahim has completed his PhD in Clinical Pharmacy from Oregon State University, USA with a minor in statistics in 2004. He is currently an associate professor and the head of Experiential Education Unit at College of Pharmacy, University of Sharjah. He has vast experience in teaching and has a large number of publications related to clinical Pharmacy and Pharmacy Practice. His research interest forced on drug use evaluation, Telepharmacy, Prescribing and Dispensing Errors, Pharmacovigilance, Diabetes Care and Therapeutic Drug Monitoring.

Dr. Panos Kanavos

Associate Professor in International Health Policy, London School of Economics, Department of Health Policy, London, | United Kingdom

An economist by training with specialisations in health economics, health care finance, the economics of medical technologies, value assessment and health technology assessment. Over 22 years of experience in working with a variety of external stakeholders, including government departments and competent authorities in more than 50 developed, emerging and low-and-middle countries worldwide; the pharmaceutical and medical device industries; international organisations; global NGOs; international industry associations; and professional and patient associations. Experienced at working in matrix environments, with a global reach and delivering effectively on complex and demanding tasks that require strategic thinking, cross-functional interaction, and providing intellectual direction, team leadership and people management. Published widely in the international peer review literature, particularly on methodological innovations and empirical analyses of health care problems. Strong believer in using sound evidence in public policy development and in communicating results across stakeholder audiences. Thriving in interactions with stakeholders that have different starting points, interests and objectives and catalysing opposing views and perspectives to seek consensus and common ground. Have influenced policy at international level on key aspects of health and pharmaceutical policy. Have innovated and developed a novel multi-criteria value framework, launched web-Delphi consensus platform and pioneered a web-based strategy tool enabling a dynamic analysis of HTA across countries, compounds and indications. Passionate about the ability of innovation to enable creative and novel approaches to health care delivery to change people’s lives and improve health outcomes; equally passionate about equitable access to health care regardless of ability to pay. Fluent in English, German and Greek; working experience of French, Spanish and Italian.

Prof. Paul W. Bush,

Pharm.D., MBA, BCPS, FASHP, Vice President for Global Resource Development and Consulting for the American Society of Health-System Pharmacists (ASHP), | USA

Paul Bush is the Vice President for Global Resource Development and Consulting for the American Society of Health-System Pharmacists (ASHP). He has held the positions of Chief Pharmacy Officer for Duke University Hospital in Durham, NC, Director of Pharmacy Services for Medical University of South Carolina, St. John Hospital and Medical Center and Detroit Osteopathic Hospital and was Corporate Director for Clinical Pharmacy Services for Horizon Health System. Dr. Bush received his B.S. in Pharmacy from the University of Michigan and Pharm.D. and M.B.A. from Wayne State University in Detroit, Michigan. He serves on the faculty of University of North Carolina Eschelman School of Pharmacy and Campbell University College of Pharmacy and Health Sciences. He previously served on the faculty of the Medical University of South Carolina (1999-2009) and Wayne State University (1984-1999) and served as Clinical Associate Dean for Medical Center and Health Systems for the South Carolina College of Pharmacy. He has served as presidential officer, board member and Chair of the Board of Directors of ASHP. Dr. Bush is Past-Treasurer of the Michigan Pharmacists Association. He has served on the Michigan Society of Health System Pharmacists Board of Directors and held the position of President-elect. Dr. Bush is Past-Chair of the ASHP Section of Pharmacy Practice Managers, Past-Chair of the University HealthSystem Pharmacy Council and has served as a member of the ASHP House of Delegates, Commission on Credentialing, Commission on Goals, and the Practice Model Summit Advisory Committee. He is a member of APhA and ACCP. Dr. Bush was awarded the John W. Webb Lecture Award by Northeastern University and ASHP, an honorary Doctor of Science degree from Campbell University, the Dean Golod Award from MUSC Health, the Distinguished Service Award by the ASHP Section of Pharmacy Practice Managers and the NCAP Pharmacy Ambassador Award He co-authored Managing and Leading – 44 Lessons Learned for Pharmacists, and chapters in Building a Successful Ambulatory Practice, Financial Management Basics for Health System Pharmacists, Handbook of Institutional Pharmacy Practice, and the Pharmacy Certified Technician Training Manual."

Prof. Peter Pitts

President and Co-Founder, Center for Medicine in the Public Interest, | USA

President, Center for Medicine in the Public Interest Visiting Professor, University of Paris Medical School Visiting Lecturer, École Supérieure des Sciences Économiques et Commerciales Former Associate Commissioner, US Food and Drug Administration • Associate Editor, Therapeutic Innovation & Regulatory Science (official DIA journal) • USA Today Expert Panel on Vaccines • External Advisory Board, IMS Institute for Healthcare Informatics in Asia • Executive Advisory Board, the Galien Foundation • Editorial Advisory Board, Food and Drug Policy Forum • Advisory Board, Journal of Commercial Biotechnology • Editorial Advisory Board, The Patient Magazine • Scientific Advisory Council. Animal Health Institute Peter Pitts is a Visiting Professor at the University of Paris Medical School and President of the Center for Medicine in the Public Interest. He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration. Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines. (CIOMS is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949.) He is the lead author of many professional peer reviewed publications including the Lancet, Therapeutic Innovation and Regulatory Science, and Nature Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and a member of the Editorial Advisory Board of The Patient Magazine. Pitts lives in New York City. Specific areas of global policy expertise include FDA policy and process, healthcare technology assessment and reimbursement issues, real world evidence, social media, off label-communications, pharmacovigilance, patient-focused drug development, abuse-deterrent opioids, biosimilar development, Rx-to-OTC switching, risk management plans, GMP policies, pharmacy education programs, drug safety, Critical Path, personalized medicine, clinical trial transparency, IP protection, FDA reform, drug importation, counterfeiting, genetically modified food issues, food safety and security, recalls, nutritional labeling. His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, Time, Newsweek, The Boston Globe, The Washington Times, The Chicago Tribune, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, The Lancet, Nature Biotechnology, BioCentury, The Journal of Commercial Biotechnology, the BBC World Service, Fox News, CNBC, Bloomberg, The PBS NewsHour, NBC Dateline, Sky News, La Stampa. L’Opinion, The Daily Show with John Stewart, among others. He has given healthcare policy presentations throughout Europe, Canada, and the United States, as well as in Russia, China, Hong Kong, Taiwan, India, the Philippines, Malaysia, Saudi Arabia, Lebanon, Oman, Israel, Turkey, The United Arab Emirates, Kuwait, Qatar, Jordan, Kenya, South Africa, Egypt, Algeria, Ukraine, Thailand, Japan, Brazil, Mexico, Vietnam, Indonesia, Singapore, Panama, Costa Rica, Argentina, and Columbia. His new book is The Value Equation: A. Journey Through the Innovation Ecosystem in the Time of COVID. He is also the author of Common-Sense Healthcare for Common Sense Americans and Become Strategic or Die, widely recognized as a cutting- edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise. A graduate of McGill University, he is married to Jane Mogel, and has two sons.

Prof. Philippe Aftimos

Clinical Trials Development Leader, Jules Bordet Cancer Institute, Brussels, . | Belgium

Dr Philippe Aftimos Consultant Hematologist and Oncologist, Clinical trials Development Leader, Jules Bordet Cancer Institute, Belgium • Department : Medical Oncology, Clinical Trials Conduct Unit (CTCU) • Hematologist & Medical Oncologist • Therapeutic Innovation Leader • Medical and Scientific Coordinator • Clinical Pharmacology Unit • Institut Jules Bordet, Brussels, Belgium

Mr. Qutaiba Al Manasee

Government Affairs Director, Middle East & Africa AstraZeneca | United Arab Emirates

Government Affairs Director, Middle East & Africa AstraZeneca

Prof. Qutayba Hamid

Vice Chancellor for Medical & Health Science Colleges and Dean, College of Medicine, University of Sharjah, | United Arab Emirates

Personal Details/Academic Background Professor Qutayba Hamid is a distinguished scientist in Respiratory Medicine and a researcher in Asthma; he is currently the Vice Chancellor for Medical and Health Sciences and the Dean of the College of Medicine in the University of Sharjah, United Arab Emirates. Prof. Qutayba was born in Mosul, Iraq. He graduated from the College of Medicine, Mosul University and was trained at the University Hospital in Mosul before travelling to the UK to continue his studies at the Imperial College of London. He served as a lecturer at the National Heart and Lung Institute in London and as a researcher on asthma and allergies. Research and Achievements: Professor Qutayba moved to McGill University in Canada in 1993 where he was appointed as an associate professor and then as a professor of Respiratory diseases. He joined the MeakinsChristie institute as a researcher and then as a Director till 2016. He held the prestigious James McGill Chair and clinical Strauss Chair in Respiratory Medicine. Recently, he was elected as a fellow of the prestigious Royal Society to become one of the few in his field to join the society. He is also a member of the Royal College of Internal Medicine in the United Kingdom, a member of the Royal College of Internal Medicine in Canada, and a visiting professor at several international universities. Professor Qutayba’s research interest is mainly focused on asthma. He has published over 500 research papers in prominent international journals, making him one of the top researchers ever to publish on Asthma, and has led to changing the concept of asthma and to the discovery of new drugs that are currently used to treat it. He has additionally contributed to the publishing of textbook chapters on Respiratory diseases. His lab in Montreal was an important training ground for respiratory professionals, graduate students and postdoctoral fellows from all over the world. Being an expert in the field of allergy, asthma and lung diseases, Professor Hamid has been elected to be a member of numerous scientific advisory boards associations and societies.

Dr. Rahma Al-Abkal

Senior Pharmacist Incharge, Ministry of Defense, | Kuwait

Certificates • 1996-1998 Diploma in Pharmaceutical Sciences (Kuwait), first class • 2004-2005 Mpharm in John Moores University (UK), second lower • 2010-2011 Master in Pharmaceutical services and medicines control Bradford University (UK), merit • 2013 International Diabetes Federation as diabetic patient educator • 2018-2021 PhD in pharmacy practice and health economics Working Experience Forced Armed Hospital, Kuwait • 12/12/1998 Starting job in Jaber Al-Ahmed Army Hospital • 1998-2004 Worked as pharmacist technician • 2009-2011 Worked as pharmacist • 2012-2014 Worked as the head of pharmacy department • 2015- Working as senior pharmacist in-charge in the medical store of the Ministry of Defense

Dr. Rana Ibrahim,

Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah. | United Arab Emirates

Dr. Rana earned her Bachelor in Pharmacy degree from Wayne State University, Michigan, USA in 2001 then earned a three years post-bachelor Doctor of Pharmacy Degree from University of Florida, Gainesville, USA in 2008. She is also a Board Certified Pharmacotherapy Specialist (2019). She has a vast teaching experience and a strong publication profile in various areas related to pharmacy practice and clinical pharmacy.

Dr. Rihaf Radhi Alfaraj

Lecturer Pharmaceutics Department, College of Pharmacy, King Saud University, | Saudi Arabia

I am a Lecturer of Microbiology, and my research is focused on finding novel biotechnological techniques to investigate bacteriocins as a replacement for the traditional antibiotics. I laid the groundwork for the proposed research during my PhD studies by developing new methods for studying protein interactions in bacterial cells in collaboration with Manchester Institute of Biotechnology. I intend to continue in this field through my research opportunities as a faculty member at KSU. I also supervised research projects for Pharmacy students as their graduation projects involved studying the antimicrobial activities of different compounds against Grampositive bacteria. I plan to improve myself and grow my passion for teaching and research by using selflearning resources and collaborating with other researchers to establish a solid ground that can contribute to future science.

Dr. Roaa Hamoud Alosaimi

Clinical Pharmacist, Security Forces Hospital, Riyadh, | Saudi Arabia

Dr. Alosaimi is clinical pharmacist at security forces hospital -Riyadh, Saudi Arabia. Dr.Alosaimi obtained her Doctorate of Pharmacy (Pharm.D.) degree from Princess Nora Bint Abdulrahman university in 2016. In 2020 Dr. Alosaimi joined the residency clinical pharmacy program at Security Forces Hospital under the Saudi Commission for Heath Specialists. In 2021 Dr.Alosaimi achieved the American Board -Certified of Pharmacotherapy specialist Dr.Alosaimi published her research study in INDO American Journal Of Pharmaceutical Science and she was involved in many research activities Dr.Alosaimi presented a number of presentations over the years inside the hospital.

Dr. Robert Franco

Senior Fellow Tufts CSDD and President, Coe Point Associates, | USA

Senior Fellow Tufts CSDD and President, Coe Point Associates,

Dr. Saba Alheialy

Assistant Professor – Immunology, College of Medicine, MBRU, Dubai, | United Arab Emirates

Saba Al Heialy obtained her PhD degree in 2013 at McGill University, Montreal, Canada. She trained at the Meakins-Christie laboratory, a leading research center in respiratory medicine under the supervision of Dr. James G. Martin. She was awarded many scholarships throughout her PhD including the James Hogg Award in 2012 for her work on nanotubes in T cells. Currently, her research revolves around the role of the immune system in various respiratory diseases with an emphasis on the association between asthma and obesity. Moreover, she has a particular interest in the role of obesity in the COVID-19 pandemic. She is funded by the Al Jalila Research Foundation for her work on the association between asthma and lung cancer.

Dr. Salah Abohelaika

Consultant Clinical Pharmacist / Pharmacogeneticist, Qatif Central Hospital, Qatif, Kingdom | Saudi Arabia

Dr. Salah Abohelaika has a Master’s Degree in Clinical Pharmacy from Pharmacy College, King Saud University, Saudi Arabia; and a Ph.D. degree in Clinical Pharmacogenetics, Institute of Cellular Medicine, Newcastle University, UK. His PhD was about “Factors (environmental and genetics) affecting the safe use of oral anticoagulants (warfarin and direct oral anticoagulants (DOACs)”. Part of his PhD was about warfarin genotyping. He supervised and lectured undergrad and postgrad students at the Institute of Cellular Medicine, Newcastle University during his Ph.D. journey. He has been working as a clinical pharmacist in MOH for around 18 years. His research expertise is in diseases pharmaco-genomics and pharmaco-epidemiology in which he published several papers. He presented his work at medical conferences in Saudi Arabia, UK, Europe, and North America.

Dr. Saleh AlMakhloof

Senior Clinical Pharmacist, Department of Pharmaceutical Care Services, King Abdulaziz Hospital, Alahsa, | Saudi Arabia

My name is Saleh Almekhloof, a senior clinical pharmacy specialist with ASHP accredited North American board since 2016; licensed to practice in Saudi Arabia ny the SCHS since 2007. My daily duties often include review of and respond to medication-related consultations for hospitalized patients mainly. Being the chairman of Medication Use Process I review and analyze medication errors as well as therapeutic interventions and come up with strategies to proactively and retrospectively prevent such issues in the future with the help of my excellent team mates; as a member of Corporate Drug Evaluation Committee I review and evaluate formulary and non-formulary medications requested by consultant physicians for formulary updates. I have been active member of several organizational committees such as Corporate & Regional Pharmaceutical & Therapeutics Committee, and Medication Safety Program at the Ministry of National Guard Health Affairs. I develop medication-related protocols, and departmental policies & procedures related to patient care. Lately I participated and succeeded in developing virtual medication counseling project, medication reconciliation project, and discharge pharmacy services. Honored to become an active speaker of ITQAN program (which is meant to enhance safe and efficient prescribing practices). I have been involved in research and publication lately: (FACCT Randomized Clinical Trial): Favipiravir & HCQ Therapy in Adults With Moderate & Severe COVID-19, The Digital Age: A Cross-Sectional Study of the Adoption Of a Personal Health Record

Dr. Saleh Ayed Al Anazi

Manager Quality Pharmaceutical care services, King Abdulaziz Medical City, Riyadh, | Saudi Arabia

Manager Quality pharmaceutical care services in King Abdulaziz medical city in Riyadh. Faculty member at the College of Pharmacy, King Saud bin Abdulaziz University for Health Science. Adjunct assistant professor at Almaarefa University. Adjunct assistant professor at Prince Sattam Bin Abdulaziz University. Surveyor in Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) in pharmacy. Hold Ph.D. degree in pharmaceutical science from King Saud University 2020, hold master degree in pharmaceutical science from king Saud University 2015, and master degree in total quality management from The Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt 2006. Also Certified Patient Safety Officer (CPSO), AIHQ since April 2015, with lots of Courses inpatient and medication Safety and quality. Certified CPHQ September 2016. Lean Six Sigma Yellow Belt Certified February 18 -19th, 2015, Lean Six-Sigma Green Certified February 20 -22, 2015. Member in Medication Safety Program in National Guard.

Mr. Salem Bin Lahej,

Director, Healthcare Fund Office, Dubai health authority (DHA) | United Arab Emirates

Director, Healthcare Fund Office, Dubai health authority (DHA)

Dr. Sara Albalushi

Director of pharmaceutical Care Dept, MOH, Oman | Oman

Negotiating Lower Drug Prices and Designing Value-based Formularies with Incremental Cost Utility Analysis

Dr. Siraj O. Abid

Pharmacist | Saudi Arabia

He has Bachelor of Pharmaceutical sciences: College of Pharmacy KING SAUD UNIVERSITY in Riyadh 1995 and Post-Graduation of business Administration: Leicester University 2010. with Excellent experiences gained through twenty five plus years of working in pharmaceutical and consumer goods field through sales, credit controlling, team building and management, resources management, forecasting, planning of actions, logistics, supply chain management, collection, regulatory affairs, manufacturing, quality, finance analysis, training and high management. Excellent development through sales career started as sales rep to sales and credit controlling manager then Regional general manager in a company listed as one of the begets pharmaceutical institution in Saudi Arabia. Licensed as Pharmaceutical Consultant from Ministry of Commerce and Industry And He provides many consultation activities to many institutes in the following subjects: Coast center management, Governmental and legal affairs, Total quality management and Assurance, Supply Chain Management, Business development, People development and Cultural development. And Feasibility studies of manufacturing of pharmaceuticals and formulary studies. He has many active Memberships Member of Saudi Pharmaceutical Society Member of Saudi Training and Development Society Vice president of Pharmacy committee in Jeddah Chamber of Commerc

Prof. Stefan Muhlebach

University of Basel, Hospital Pharmacist FPH, Dept of Pharmaceutical Sciences, Div Clinical Pharmacy & Epidemiologie / Hospsital Pharmacia, | Switzerland

Education, University Teaching & Research, Memberships and Distinctions Stefan Mühlebach is a pharmacist and pharmacologist by training, working 1970-2005 as a (parttime) researcher at the Institute of Pharmacology in Bern on a project granted by the Swiss National Foundation. After his PhD thesis in 1979, he did his habilitation (university teacher) in 1993 at the Medical Faculty of the University of Bern and in 2000 in Basel where he was appointed Professor for Pharmacology and Hospital Pharmacy in 2004. He works as an external member at the Institute of Clinical Pharmacy & Epidemiology • Hospital Pharmacy at Basel. He directed so far 11 PhD, many Ms theses and published about 200 reviewed scientific papers, book chapters and guidelines with about 4500 citations and an i10 index of 53 (https://scholar.google.com/citations?user=rgN3-rwAAAAJ&hl=de ). His scientific interests are pharmacology, hospital pharmacy, clinical nutrition, nanomedicines, and regulatory sciences. He is a Faculty Member of the European Association of Parenteral and Enteral nutrition (ESPEN) contributing to basic learning books, educational courses and co-authoring national and international guidelines on clinical nutrition. He became a honorary member of the Swiss Association of Hospital Pharmacists in 2012, served as Board Member and journal editor of the European Association of Hospital Pharmacists (EAHP), for many years. He is a Fellow of the Swiss Academia of Pharmaceutical Sciences. In 2019 he got a Dr.h.c. from the Pharmacy Faculty of the Semmelweis University in Budapest. Professional activities Stefan Mühlebach worked for 25 years as chief hospital pharmacist in Switzerland, initiated the postgraduate specialization in hospital pharmacy in the 90ties and supervised the first hospital pharmacy fellows in Switzerland. Stefan Mühlebach worked from 2005-2008 with the National Agency for Therapeutic Products (Swissmedic) as Head of the Pharmacopoeia and of the Swiss Delegation at the EDQM in Strasbourg (Pharmacopoeia Europea). As an industrial pharmacist he joined Vifor Pharma Ltd and worked from 2008-2019, first as a Chief Scientific Officer in the Swiss subsidiary, afterwards as a Regulatory Science Lead for NonBiological Complex Drugs (NBCDs) / nanomedicines at the international headquarter focusing on their regulatory challenges. He chaired the NBCD Working Group at Lygature in the Netherland from its beginning in 2009 to 2019. Since 2010 he is in a part-time job at the Federal Office of National Economic Supply (FONES) as Head of Therapeutic Products to manage drug shortages in Switzerland. Actually, he is also in charge in a part-time job as head of the working group on logistics for the covid-19 vaccines in Switzerland at the Federal Office of Public Health.

Dr. Suhail Al-Amad,

Oral and Craniofacial Health Sciences, Dental Medicine College, University of Sharjah | United Arab Emirates

• Associate Professor at the University of Sharjah (UAE) • Consultant in Oral Medicine at the University Hospital Sharjah • Chairman of the University of Sharjah’s Research Ethics Committee

Dr. Sultan Al Raddadi

Cardiovascular Pharmacotherapy Consultant, Cardiology Cinical Pharmacist, King Abdulaziz Medical City (KAMC), | Saudi Arabia

Dr. Sultan Al Raddadi, is cardiovascular pharmacotherapy consultant, working as cardiology clinical pharmacist at King Abdulaziz medical city (KAMC). He joined KAMC in 2004 as outpatient pharmacist and get his general clinical pharmacy board in 2009. In 2014 he get his cardiovascular pharmacotherapy board and in 2021 he become board certified cardiology pharmacist. He started his clinical pharmacy carrier in ICU in 2011 for 5 months, then nephrology till 2013, and finally king Abdulaziz cardiac center for the last 8 years. He is also a member in Advance Heart failure and heart transplant team at King Abdulaziz Cardiac Center. He is an anticoagulation expert since he is practicing in the anticoagulation clinic since 2011. Dr. Sultan is interested in training and teaching since he is a joint appoint faculty at KSAU-HS and residency preceptor at SCFHS. He was awarded as best tutor in pharmacy National Guard residency program in 2019. Sultan present many lecture in both symposiums and in site. Dr. Sultan is also a member in corporate drug evaluation committee since 2015, and Saudi society of clinical pharmacy

Dr. Thuraya Nasser Bumozah

Clinical Pharmacist, Department of Pharmacy, MCH Hospital, Alhasa, | Saudi Arabia

Thuraya bumozah is a clinical pharmacist at the Maternity and children hospital (MCH), Alhasa-KSA. Dr.Thuraya earned her Bachelor’s degree in Pharmaceutical Sciences with honors from King Saud University in 2004 and her Master of Clinical Pharmacy from College of Pharmacy, The University of Queensland, Australia in 2010. Dr.Thuraya has more than 16 years’ experience working at Ministry Of Heath as hospital pharmacist; 10 years of them as a clinical pharmacist in the Pediatric intensive care unit. In January 2018 she was appointed as the executive director of academic and training affairs at the Maternity and children hospital Al Ahsa Thuraya participated in a large number of local scientific meetings as a speaker or organizer. She coordinated and supervised clinical pharmacy students' training programs at the hospitals where she participated in the preparation of continuing educational program, for pharmacy staff, and staff development and was appointed with several administrative pharmacy positions as a supervisor. Other areas of interest include quality improvement and medication safety.

Dr. Waleed M. Alshehri

Senior Clinical Pharmacist, King Fahad Medical City (KFMC), | Saudi Arabia

Dr. Waleed Alshehri is currently working as a senior clinical pharmacist specialized in pain management/palliative care, clinical pharmacy department, pharmacy administration, King Fahad Medical City (KFMC), Riyadh. Dr. Alshehri graduated from the pharmacy college at King Saud University in Riyadh with a bachelor’s degree in pharmaceutical sciences in 2000. After his graduation, he worked as a staff pharmacist in different pharmacy sections (outpatient pharmacy, Unit Dose pharmacy, I.V admixture room, Chemo-room, extemporaneous preparation pharmacy, drug information and satellite pharmacies) at Security Forces Hospital in Riyadh. In 2005, Dr. Alshehri joined KFMC and established the ICUs Satellite pharmacy, where he worked until 2008. Dr. Alshehri was awarded a scholarship in 2008 from KFMC to complete his subspecialty from the United Kingdom. In 2010, he obtained his master’s degree in pain management from the University of Leicester, UK. After returning to KFMC, he joined two departments, the pain management and palliative care departments, as a clinical pharmacist for 3 years. In 2013, he was awarded a scholarship from KFMC to complete post-graduate training in the clinical pharmacy field in North America. In 2017, he obtained his Doctor of Pharmacy degree (Pharm.D.) from Massachusetts Colleague of Pharmacy and Health Sciences, MCPHS University, Boston, USA. He resumed back his clinical pharmacy duties with pain management and palliative care. In 2018, Dr. Alshehri was assigned as the medication safety officer, where he was established the new Drug Safety and Pharmacovigilance Unit and worked as the head of the Unit in KFMC. In addition to his clinical practice and management positions, he is a clinical adjunct professor for various universities (Princess Nourah University, King Saudi University, and Almaarefa University). Dr. Alshehri has joined the ISMP Practitioner in Resident Program (ISMP-PIR) in Pennsylvania, USA. He has been certificated in patient safety, medication safety, risk management (CPSO, CMSO, CHRM), and a registered CBAHI surveyor. He is the counterpart for national and international accreditation in KFMC, pharmacy chapter, and member of the accreditation team, KFMC. Dr. Alshehri is a member of the International Association for the Study of Pain, the Saudi Society of Pain Medicine, and the American Society of Health-System Pharmacists (ASHP).

Dr. Ward Saidawi

Sharjah Institute for Medical Services, University of Sharjah | United Arab Emirates

Sharjah Institute for Medical Services, University of Sharjah

Dr. Wegdan Bani Issa,

Nursing/health sciences, University of Sharjah | United Arab Emirates

Dr. Wegdan completed her bachelor's degree at Jordan University of Science and Technology in nursing, her master's degree at the University of Windsor/Ontario in Canada, and her doctoral studies at the University of Kansas Medical Centre in the United States. She specialises in women's health and informatics/electronic health records. She is currently working as an associate professor at the University of Sharjah and has published several papers in the field of women's health and population health in general. She has received several grants and awards in the area of public health. She is the founder of the health promotion research group at the university of Sharjah

Dr. Yaqoob Alhadhrami

Clinical Pharmacist | Oman

2021- Currently works as a clinical pharmacist in acute medicine in Nizwa hospital. 2017 -2021 Worked as the head of pharmaceutical services in Nizwa Hospital- Sultanate of Oman. Obtained bachelor of pharmacy from Oman Medical College, Sultanate of Oman in November 2009. Obtained Master of Science in Clinical Pharmacy. Graduated from University of Strathclyde, UK in September 2014. Pediatric clinical pharmacist covering pediatric critical care units along with medical ward. Works as a medication safety officer in Nizwa Hospital. Member of research, drug and therapeutic committee in the hospital.

Dr. Yazed S. AlRuthia

Associate Professor of Health Policy and Pharmacoeconomics, Director of the Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, | Saudi Arabia

Yazed Sulaiman AlRuthia was born in Riyadh, Saudi Arabia. He completed his bachelor degree in pharmaceutical sciences back in 2007 from King Saud University College of Pharmacy in Riyadh, Saudi Arabia. He did his pharmacy internship at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. Thereafter, he worked for a short period of time in the Pharmacy Care Services at King Abdulaziz Medical City in Riyadh, Saudi Arabia. Then, he moved to the College of Pharmacy at King Saud University, where he graduated from, to work as a teaching assistant in the department of clinical pharmacy between June 2007 and June 2018. At that time, he was granted a scholarship to pursue his post-baccalaureate Doctor of Pharmacy Degree (Pharm.D) from Massachusetts College of Pharmacy and Health Sciences, and earned the degree back in May 2011. Afterwards, he moved to the city of Memphis in the state of Tennessee in the United States to pursue his Doctor of Philosophy (PhD) degree in Health Outcomes and Policy with emphasis on Pharmacoeconomics from the University of Tennessee Health Science Center, and earned his degree back in May 2015. Dr. AlRuthia is now an associate professor of health policy and economics at King Saud University College of Pharmacy and active clinical researcher where he published more than 50 research articles since he came back. His research interests are broad and range from health policy (e.g., community pharmacy regulations, healthcare providers’ payment models, dietary supplements regulations, drug shortages), social pharmacy (e.g., medication adherence, beliefs about medications, health literacy, medication knowledge, patient-healthcare provider relationship), medication safety, health economics and patient reported outcomes (eg., comparative effectiveness, cost analysis, health-related quality of life), and education strategies and outcomes (e.g., active learning, identifying gaps in health education).

Prof. Yola Moride

Center for Pharmacoepidemiology & Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, . | USA

ola Moride, a pharmacoepidemiologist, joined PETS on a part-time basis in 2017 as a Research Professor. She received her Ph.D. in Pharmacoepidemiology from McGill University (1994) and post-doctoral training from University of Bordeaux (1996). She has pursued an academic career at Université de Montréal since 1996. She is Past-President of the International Society for Pharmacoepidemiology (ISPE) and past-Vice-President of the International Society of Pharmacovigilance (ISoP). She serves on the Steering Group of the European Network of Centers in Pharmacoepidemiology and Pharmacovigilance (ENCePP) at the European Medicines Agency. She has conducted several observational studies in the area of neurologic and psychiatric pharmacoepidemiology as well as therapeutic risk management. Studies include the effect of benzodiazepines on dementia and antidepressants in youth. Recently, she has conducted studies on the effectiveness of risk minimization interventions on opioid usage and opioid related harms as well as on the predictors of chronic opioid use. She is the founder and owner of YolaRX Consultants.

Mr. Yousef Al Kindri,

Chairman, Kuwait's Multiple Sclerosis Association | Kuwait

r. Yousef Al Kindri, Kuwait Chairman, Kuwait's Multiple Sclerosis Association

Dr. Zahid Hussain,

Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah | United Arab Emirates

Dr. Zahid Hussain (H-index 30, i-10 index 61) has authored 100+ articles in high impact factor international journals and 5 book chapters. He is recipient of several prestigious honors and awards including outstanding Scientist Award in 2020. He has been featured among Top 2% Scientists in the World (2021) based on Scopus Citation Index.

Dr. Zainab Al Hashimy

Sr.Specialized Pharmacist | Oman

Zainab Al-Hashimy is Sr. Specialized Pharmacist Plastic and Reconstruction surgery Department and Hand Surgery Department. She graduated from Ajman University of Science & Technology, Faculty of Pharmacy & Health Sciences, United Arab Emirates. Then, she joined Khoula Hospital, Ministry of health, Oman in 2006. From then, she starts her journey in Pharmacy career. She was active and fast learning in pharmacy management, and she uses her positive attitude and tireless energy to encourage others to work hard and succeed. In fact, she gets here first position as 2nd in charge of OPD pharmacies from 2006 to 2009. In 2009, she become head of Inpatient Pharmacy until she went to get her higher education in clinical pharmacy specialty which she was practicing the clinical pharmacy since 2008. She gets her MScs. Pharmacotherapy and Medicines Management. University of Sunderland. Faculty of Applied Sciences. UK, 2011. Moreover, she was member of Education & Training committee of pharmacy, hospital information system committee, Plastic and Reconstruction Department Meeting and in antimicrobial stewardship committee. In addition, she was member of taskforce committee to design the intervenes Therapy compendium for all health care practitioners in Oman in 2016. During her work, she participates in many conferences as speakers. She has two published paper. In 2020, she become the chairperson of Pharmacy Research committee. She ambitions to encourage all pharmacist to be involve in research and study. At the end, she is very happy to guide and help the one who need her advice in research.